Newsroom
Bausch &
Lomb Schedules Conference Call to Update Investors on
ReNu® with MoistureLoc® Situation
FOR RELEASE TUESDAY APRIL 11,
2006
Rochester, NY --- Bausch & Lomb (NYSE:BOL) will hold a conference call to discuss the current situation regarding U.S. sales of ReNu® with MoistureLoc® solutions. Chairman and CEO Ronald L. Zarrella and Senior Vice President and CFO Stephen C. McCluski will update investors and answer questions.
Investor Conference Call Information
Wednesday, April 12,
2006
8:30 a.m. (ET)
The News Media is invited to listen only on this call.
Call-in Number: 913.981.5542
Rebroadcast Number:
719.457.0820
Confirmation 2047677
The rebroadcast of the
conference call will be available starting at
1:30 p.m. ET through midnight April 16, 2006.
Additionally, the investor call will be broadcast live over the Internet. It can be accessed from the Investor Relations page of the Company's Web site, www.bausch.com , or at www.vcall.com .
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com . Copyright Bausch & Lomb Incorporated.
® / TM denote trademarks of Bausch & Lomb Incorporated.
